Concepedia
Statistics
Publications
87
Citations
5.8K
H-Index
39
Active since
1968
Affiliations
Takeda (United States)(Current)
Deerfield (United States)
Pharmaceutical Product Development (United States)
Sears Holdings (United States)
Aziz Karim is an author at Takeda (United States) specializing in pharmacology, pharmacokinetics, and medicine.
Publications per year
1968–2015
The pharmacokinetics of Norpace.
Aziz Karim · PubMed · 1975 · 555 citations
Pharmacy, Pharmacokinetics, Pharmacology +4
Tumor inhibitors. LXXIII. Maytansine, a novel antileukemic ansa macrolide from Maytenus ovatus
S. Morris Kupchan, Yasuo Komoda, William A. Court et al. · Journal of the American Chemical Society · 1972 · 432 citations
Medicine, Medicinal Chemistry, Pharmacology +6
Effects of Celecoxib, a Novel Cyclooxygenase‐2 Inhibitor, on Platelet Function in Healthy Adults: A Randomized, Controlled Trial
Philip T. Leese, Richard C. Hubbard, Aziz Karim et al. · The Journal of Clinical Pharmacology · 2000 · 374 citations
Medicine, Pharmacology, Pharmacotherapy +15
Pharmacokinetics of Celecoxib after Oral Administration in Dogs and Humans: Effect of Food and Site of Absorption
Susan K. Paulson, Margaret B. Vaughn, Susan M. Jessen et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 286 citations
Pharmacy, Pharmacokinetics, Pharmacology +17
Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia
Evert de Jonge, Pascale E. P. Dekkers, Abla A. Creasey et al. · Blood · 2000 · 256 citations
Medicine, Immunology, Pharmacology +12
1–5 of 87